MME
REGN icon

Meag Munich Ergo’s Regeneron Pharmaceuticals REGN Stock Holding History

Meag Munich Ergo’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-1,276
Closed -$477K – 444
2019
Q4 		$477K Sell
1,276
-3,958
-76% -$1.33M 0.05% 279
2019
Q3 		$1.43M Buy
5,234
+2,244
+75% +$664K 0.07% 288
2019
Q2 		$930K Hold
2,990
– – 0.07% 270
2019
Q1 		$1.21M Buy
+2,990
New +$1.23M 0.1% 220
2018
Q1 		– Sell
-3,679
Closed -$1.42M – 487
2017
Q4 		$1.42M Buy
+3,679
New +$1.49M 0.05% 321

Other funds holding REGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Polen Capital Management
Polen Capital Management Boca Raton, Florida $14.5B AUM 5.7% 1-Year Est. Return

Meag Munich Ergo's REGN Position: Q1 2020 in Review

Meag Munich Ergo sold out of Regeneron Pharmaceuticals (REGN) in Q1 2020, closing a stake of 1,276 shares — an estimated $477K sold.

Meag Munich Ergo first reported a position in REGN in Q4 2017 and held it in 5 quarters. The position peaked at $1.43M in Q3 2019. 816 funds tracked by Wall St. Rank hold REGN as of Q1 2020.

  • Meag Munich Ergo reported no remaining Regeneron Pharmaceuticals position as of Q1 2020 after selling out during the quarter.
  • Meag Munich Ergo sold 1,276 Regeneron Pharmaceuticals shares in Q1 2020, an estimated $477K.
  • Meag Munich Ergo first reported a position in Regeneron Pharmaceuticals in Q4 2017 and held it in 5 quarters.
  • Meag Munich Ergo's Regeneron Pharmaceuticals position peaked at $1.43M in Q3 2019.
  • 816 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q1 2020.

Based on Meag Munich Ergo's 13F filing for Q1 2020, filed 23 Apr 2020.